Table 1 Patient clinical characteristics.

From: New Labyrinth Microfluidic Device Detects Circulating Tumor Cells Expressing Cancer Stem Cell Marker and Circulating Tumor Microemboli in Hepatocellular Carcinoma

Clinical Characteristics

 

n (%)

Age (y)

Median (66); Range (54–88)

  

AFP (ng/mL)

≤20

22 (53.66%)

Median (17); Range (1–162650)

>20

19 (46.34%)

Tumor size (cm)

≤5

22 (52.38%)

Median (4.6); Range (0–10.8)

>5

19 (45.24%)

Tumor number

Single

22 (52.38%)

Multiple

13 (30.95%)

TNM stage

T0

1 (2.4%)

I

15 (35.7%)

II

8 (19%)

III

12 (28.6%)

IV

6 (14.3%)

BCLC stage

0

3 (7.1%)

A

11 (26.2%)

B

15 (35.7)

C

13 (30.95)

Cirrhosis

No

7 (16.67%)

Yes

35 (83.33%)

Macrovascular invasion

No

32 (76.19%)

Yes

10 (23.81%)

Etiology

HCV

24 (57.14%)

HBV

0 (0%)

ETOH

4 (9.52%)

NASH

10 (23.81%)

None

4 (9.52%)

Back to article page